Lieve Gyselbrecht
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments 6
- Systemic Lupus Erythematosus Research 4
- Rheumatoid Arthritis Research and Therapies 4
- Osteoarthritis Treatment and Mechanisms 1
- Hematology top 10%
-
- Psoriasis: Treatment and Pathogenesis 3
-
- Vasculitis and related conditions 1
-
- Inflammatory Myopathies and Dermatomyositis 1
-
- Peripheral Neuropathies and Disorders 1
Lieve Gyselbrecht
9 papers receiving 340 citations
Peers
Comparison fields: 5 of 46
- Rheumatology 280
- Hematology 96
- Immunology 128
- Dermatology 32
- Genetics 95
Countries citing papers authored by Lieve Gyselbrecht
This map shows the geographic impact of Lieve Gyselbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieve Gyselbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieve Gyselbrecht more than expected).
Fields of papers citing papers by Lieve Gyselbrecht
This network shows the impact of papers produced by Lieve Gyselbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieve Gyselbrecht. The network helps show where Lieve Gyselbrecht may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lieve Gyselbrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 19 | |
| 2 | 2018 | 3 | |
| 3 | 2018 | 30 | |
| 4 | 2014 | 5 | |
| 5 | Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. | 2006 | 36 |
| 6 | Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis. | 1997 | 27 |
| 7 | The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. | 1995 | 150 |
| 8 | Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. | 1995 | 66 |
| 9 | Influence of interferon-gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. | 1993 | 11 |
About Lieve Gyselbrecht
Lieve Gyselbrecht is a scholar working on Rheumatology, Immunology and Dermatology, having authored 9 papers that have together received 347 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (6 papers), Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Vasculitis and related conditions (1 paper), Inflammatory Myopathies and Dermatomyositis (1 paper), Peripheral Neuropathies and Disorders (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Rheumatology (280 citations), Hematology (96 citations) and Immunology (128 citations). Lieve Gyselbrecht has collaborated with scholars based in Belgium, Japan and Italy. Frequent co-authors include L Schatteman, Herman Mielants, Dirk Elewaut, Stefan Goemaere, Claude Cuvelier, Veys Em, De Vos M, L De Clercq, Eric Veys and M. De Vos. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.